A carregar...
2SPD-006 Analysis of rituximab off-label use in a tertiary hospital
BACKGROUND: The implementing Law 1015/2009 normalises the compassionate use of investigational drugs, access to off-label and unauthorised drugs in Spain. Rituximab is an anti-CD20 monoclonal antibody widely used in off-label conditions to treat autoimmune diseases.(1,2,3,4) PURPOSE: The creation of...
Na minha lista:
| Publicado no: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535219/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.27 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|